Search Results | DrugBank Online

Displaying drugs 14501 - 14525 of 15252 in total

AMZ002

AMZ002 is a sterile injectable hormone developed as a purified synthetic polypeptide alternative to current FDA-approved epileptic seizure treatments.

Investigational

IMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen, designed to stop the progression of multiple sclerosis (MS) and the destruction of the myelin sheath protecting the nerves.

Investigational

Matched Description: … Glycoprotein), a dominant autoantigen, designed to stop the progression of multiple sclerosis (MS) and …

AVI-014

AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF).

Investigational

Autologous Human Peripheral Blood Lymphocytes

Investigational

P140K methylguanine-DNA-methyltransferase mutant CD34+ cells

Investigational

SRX-1177

Investigational

ATG-101

ATG-101 is a novel PD-L1/4-1BB bispecific antibody that was designed to block the binding of immunosuppressive PD-1/PD-L1 and conditionally induce 4-1BB stimulation, thus activating anti-tumor immune effectors, while delivering enhanced anti-tumor activity, with an improved safety profile.

Investigational

Matched Description: … PD-L1/4-1BB bispecific antibody that was designed to block the binding of immunosuppressive PD-1/PD-L1 and …

Activated natural killer cell therapy

Investigational

Adenovirus/PNP

Investigational

ETBX-041

Investigational

Carlecortemcel-L

Investigational

PBCAR269A

Investigational

PBCAR20A

Investigational

P-2045 Re-188

Investigational

ALM201

ALM201 is an anti-angiogenic synthetic peptide identified from the endogenous human protein, FKBPL. It is being investigated in the treatment of various cancers.

Investigational